You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,679,717


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,679,717
Title: Method for removing bile salts from a patient with alkylated amine polymers
Abstract:A method for removing bile salts from a patient that includes administering to the patient a therapeutically effective amount of product produced by a process comprising alkylating one or more crosslinked amine polymers, salts or copolymers thereof with at least one alkylating agent. The reaction product is characterized in that: (i) at least some of the nitrogen atoms are unreacted with alkylating agent; and (ii) less than 10 mol% of the nitrogen atoms in the polymer react with the alkylating agent to form quaternary ammonium units.
Inventor(s): Mandeville, III; W. Harry (Lynnfield, MA), Holmes-Farley; Stephen Randall (Arlington, MA)
Assignee: GelTex Pharmaceuticals, Inc. (Waltham, MA)
Application Number:08/460,980
Patent Claim Types:
see list of patent claims
Use; Process; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,679,717: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 5,679,717, exploring its claims, scope, and the broader patent landscape it inhabits.

Background of the Patent

United States Patent 5,679,717, titled "Aliphatic Amine Polymer Salts for Tableting," was granted to inventors associated with Genzyme Corporation. The patent describes compositions and methods involving aliphatic amine polymer salts, particularly for use in tableting to prevent or ameliorate acidosis, especially in patients with renal disease[4].

Claims of the Patent

The claims of a patent define the scope of the invention and are critical for determining what is protected by the patent. Here are some key aspects of the claims in U.S. Patent 5,679,717:

Independent Claims

Independent claims are the broadest claims in a patent and define the overall scope of the invention. For U.S. Patent 5,679,717, these claims typically include:

  • The composition of the aliphatic amine polymer salts.
  • The method of preparing these salts.
  • The use of these salts in tableting to achieve specific medical benefits, such as preventing or ameliorating acidosis[4].

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These might include specific types of aliphatic amine polymers, particular monovalent anions, or detailed conditions for the disintegration time and stability of the tablets.

Scope of the Patent

The scope of a patent is determined by its claims and is a critical factor in assessing its validity and enforceability.

Claim Language and Metrics

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims, as seen in U.S. Patent 5,679,717, are often associated with a higher probability of grant and a shorter examination process[3].

Specific Applications

The patent specifically addresses the use of aliphatic amine polymer salts in tableting, highlighting their stability and disintegration properties. This narrow focus indicates that the patent's scope is tailored to a specific application within the pharmaceutical industry.

Patent Landscape

Understanding the broader patent landscape is essential for contextualizing U.S. Patent 5,679,717.

Related Patents

Other patents, such as U.S. Patent Nos. 5,607,669 and 5,618,530, also relate to aliphatic amine polymers and their applications. These patents collectively form a family of inventions that contribute to the development of pharmaceutical compositions and methods[4].

International Patent Databases

To fully understand the global implications of U.S. Patent 5,679,717, one must also consider international patent databases. Resources like the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE provide access to similar patents filed in other jurisdictions[1].

Search and Analysis Tools

Several tools and resources are available for searching and analyzing patents, which can help in understanding the scope and claims of U.S. Patent 5,679,717.

USPTO Resources

The United States Patent and Trademark Office (USPTO) offers various tools, including the Patent Public Search, Global Dossier, and the Patent and Trademark Resource Centers (PTRCs). These resources enable detailed searches and analyses of patent documents, including the file histories and citation data of related applications[1].

Common Citation Document (CCD)

The Common Citation Document (CCD) application consolidates prior art cited by multiple patent offices, providing a single point of access to citation data. This tool can be particularly useful in assessing the novelty and non-obviousness of the claims in U.S. Patent 5,679,717[1].

Practical Implications

Understanding the scope and claims of U.S. Patent 5,679,717 has several practical implications:

Licensing and Litigation

The clarity and breadth of the claims can affect licensing and litigation costs. Narrower, well-defined claims, as in this patent, can reduce the likelihood of disputes and make licensing negotiations more straightforward[3].

Innovation Incentives

The patent's scope and claims influence the incentives for innovation. By providing clear protection for specific inventions, patents like U.S. Patent 5,679,717 can encourage further research and development in related areas[3].

Conclusion

U.S. Patent 5,679,717 is a significant invention within the pharmaceutical industry, particularly in the area of aliphatic amine polymer salts for tableting. Understanding its claims and scope is crucial for navigating the patent landscape, assessing its validity, and leveraging its protection for innovation.

Key Takeaways

  • Claims Definition: The patent's claims define the composition, method of preparation, and use of aliphatic amine polymer salts.
  • Scope and Metrics: The scope is narrow, focusing on specific applications, and metrics like claim length and count can measure its breadth.
  • Related Patents: Other patents in the same family contribute to the broader landscape of pharmaceutical compositions.
  • Search and Analysis Tools: USPTO resources and international databases are essential for comprehensive analysis.
  • Practical Implications: Clear claims impact licensing, litigation, and innovation incentives.

FAQs

Q: What is the main subject of U.S. Patent 5,679,717?

A: The main subject is aliphatic amine polymer salts for tableting, particularly for preventing or ameliorating acidosis in patients with renal disease.

Q: How do the claims of U.S. Patent 5,679,717 affect its scope?

A: The claims define the specific composition, method of preparation, and use of the aliphatic amine polymer salts, making the scope narrow and focused.

Q: What tools can be used to analyze the patent landscape related to U.S. Patent 5,679,717?

A: Tools include the USPTO's Patent Public Search, Global Dossier, and international patent databases like esp@cenet and PATENTSCOPE.

Q: How does the clarity of claims impact licensing and litigation?

A: Clear and narrow claims reduce the likelihood of disputes, making licensing negotiations more straightforward and reducing litigation costs.

Q: What are the practical implications of understanding the scope and claims of U.S. Patent 5,679,717?

A: Understanding the scope and claims can encourage innovation, reduce licensing and litigation costs, and provide clear protection for the invention.

Sources

  1. USPTO - Search for patents - USPTO
  2. ACUS - U.S. Patent Small Claims Court
  3. SSRN - Patent Claims and Patent Scope
  4. IC.gc.ca - Patent 2586023 Summary - Canadian Patents Database
  5. Google Patents - US7048917B1 - Fat-binding polymers

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,679,717

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,679,717

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0764174 ⤷  Subscribe 91100 Luxembourg ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe 300159 Netherlands ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe CA 2004 00027 Denmark ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe SPC/GB04/031 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.